Literature DB >> 10709758

Estrogen downregulates neuronal nitric oxide synthase in rat anterior pituitary cells and GH3 tumors.

X Qian1, L Jin, R V Lloyd.   

Abstract

The anterior pituitary gland produces neuronal nitric oxide synthase (nNOS) and nitric oxide regulates secretion of various anterior pituitary hormones. Estrogen has many functions in anterior pituitary cells including stimulation of prolactin (PRL) cell proliferation and secretion of various anterior pituitary hormones. However, the role of estradiol-17beta (E2) in regulating pituitary nNOS expression has not been previously examined. We studied the regulation of nNOS in normal pituitaries, and neoplastic GH3 pituitary tumors in order to analyze the effects of E2 on nNOS in pituitary cells. GH3 tumors expressed higher levels of nNOS proteins compared to normal pituitaries. Estrogen downregulated nNOS mRNA and protein in both estrogen-treated pituitaries with PRL cell hyperplasia and in GH3 tumors implanted into the flank of rats treated with E2 in silastic tubing. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis demonstrated three alternatively spliced nNOS transcript isoforms--nNOSa, nNOSb, and nNOSc mRNAs--with distinct 5' untranslated first exons that arose from alternative splicing to a common second exon. All three spliced isoforms were found in the normal rat pituitary, whereas nNOSa and nNOSb, but not nNOSc, were expressed in GH3 tumors implanted into Wistar-Furth rats. E2 also downregulated the nNOSa alternative mRNA transcript isoform in vivo. These results indicate that the biological activity of nNOS in the normal rat anterior pituitary and in pituitary tumors is regulated by a complex pattern of alternative splicing and that some of these mRNA isoforms as well as nNOS protein are regulated by estrogen. Our results also indicate that the levels of nNOS and the alternatively spliced nNOS transcript between normal and GH3 pituitary tumors are different.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10709758     DOI: 10.1385/ENDO:11:2:123

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  34 in total

1.  Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase.

Authors:  D S Bredt; P M Hwang; C E Glatt; C Lowenstein; R R Reed; S H Snyder
Journal:  Nature       Date:  1991-06-27       Impact factor: 49.962

2.  Strong inhibition of neuronal nitric oxide synthase by the calmodulin antagonist and anti-estrogen drug tamoxifen.

Authors:  A Renodon; J L Boucher; M A Sari; M Delaforge; J Ouazzani; D Mansuy
Journal:  Biochem Pharmacol       Date:  1997-11-15       Impact factor: 5.858

Review 3.  Cytokines: autocrine and paracrine roles in the anterior pituitary.

Authors:  E Arzt; G K Stalla
Journal:  Neuroimmunomodulation       Date:  1996 Jan-Feb       Impact factor: 2.492

4.  Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro.

Authors:  A Costa; P Trainer; M Besser; A Grossman
Journal:  Brain Res       Date:  1993-03-12       Impact factor: 3.252

5.  Central inhibition of nitric oxide synthase preferentially augments release of oxytocin during dehydration.

Authors:  J Y Summy-Long; V Bui; S Mantz; E Koehler; J Weisz; M Kadekaro
Journal:  Neurosci Lett       Date:  1993-04-02       Impact factor: 3.046

6.  Involvement of nitric oxide in growth hormone (GH)-releasing hormone-induced GH secretion in rat pituitary cells.

Authors:  M Kato
Journal:  Endocrinology       Date:  1992-11       Impact factor: 4.736

7.  Identification and characterization of a calmodulin-dependent nitric oxide synthase from GH3 pituitary cells.

Authors:  D J Wolff; G A Datto
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

8.  Neuronal nitric oxide synthase alternatively spliced forms: prominent functional localizations in the brain.

Authors:  M J Eliasson; S Blackshaw; M J Schell; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

9.  Nitric oxide synthase type I and type III gene expression are developmentally regulated in rat lung.

Authors:  A J North; R A Star; T S Brannon; K Ujiie; L B Wells; C J Lowenstein; S H Snyder; P W Shaul
Journal:  Am J Physiol       Date:  1994-06

10.  Role of nitric oxide in control of prolactin release by the adenohypophysis.

Authors:  B H Duvilanski; C Zambruno; A Seilicovich; D Pisera; M Lasaga; M C Diaz; N Belova; V Rettori; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

View more
  5 in total

1.  17β-oestradiol acts as a negative modulator of insulin-induced lactotroph cell proliferation through oestrogen receptor α, via nitric oxide/guanylyl cyclase/cGMP.

Authors:  S Gutiérrez; J P Petiti; L d V Sosa; L Fozzatti; A L De Paul; A M Masini-Repiso; A I Torres
Journal:  Cell Prolif       Date:  2010-10       Impact factor: 6.831

2.  Tetrahydrobiopterin restores diastolic function and attenuates superoxide production in ovariectomized mRen2.Lewis rats.

Authors:  Jewell A Jessup; Lili Zhang; Tennille D Presley; Daniel B Kim-Shapiro; Hao Wang; Alex F Chen; Leanne Groban
Journal:  Endocrinology       Date:  2011-03-22       Impact factor: 4.736

3.  Neuronal nitric oxide synthase inhibition improves diastolic function and reduces oxidative stress in ovariectomized mRen2.Lewis rats.

Authors:  Jewell A Jessup; Lili Zhang; Alex F Chen; Tennille D Presley; Daniel B Kim-Shapiro; Mark C Chappell; Hao Wang; Leanne Groban
Journal:  Menopause       Date:  2011-06       Impact factor: 2.953

4.  Growth hormone-releasing hormone and gonadotropin-releasing hormone stimulate nitric oxide production in 17beta-estradiol-primed rat anterior pituitary cells.

Authors:  Michihiro Tsumori; Yoshio Murakami; Kunio Koshimura; Yuzuru Kato
Journal:  Endocrine       Date:  2002-04       Impact factor: 3.633

5.  Nitric Oxide Plays a Key Role in Ovariectomy-Induced Apoptosis in Anterior Pituitary: Interplay between Nitric Oxide Pathway and Estrogen.

Authors:  Sonia A Ronchetti; Leticia I Machiavelli; Fernanda A Quinteros; Beatriz H Duvilanski; Jimena P Cabilla
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.